Karlyne M. Reilly

4.0k citations

57 papers · 2.3k indexed · h-index 24

Neurology top 1%
- Neurofibromatosis and Schwannoma Cases 19
- Neuroblastoma Research and Treatments 13
Genetics top 2%
- Glioma Diagnosis and Treatment 14
Oncology top 10%
- Cancer-related Molecular Pathways 6
Developmental Neuroscience top 10%
Pulmonary and Respiratory Medicine top 5%
- Sarcoma Diagnosis and Treatment 9
Cell Biology
- Microtubule and mitosis dynamics 7
Molecular Biology
- Chromatin Remodeling and Cancer 5
Surgery
- Adrenal and Paraganglionic Tumors 5

Co-authors: Tyler Jacks Margaret E. McLaughlin Dagan A. Loisel Roderick T. Bronson Jessica J. Hawes Jessica C. Walrath Douglas A. Melton Karen Cichowski
Cited by: Neurology Genetics Oncology
Journals: Cancer Research (4 papers)Neuro-Oncology (3 papers)Mammalian Genome (3 papers)
Partner nations: United States Canada India

In The Last Decade

Karlyne M. Reilly

55 papers receiving 2.2k citations

Peers

Countries citing papers authored by Karlyne M. Reilly

Since Specialization

Citations

This map shows the geographic impact of Karlyne M. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karlyne M. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karlyne M. Reilly more than expected).

Fields of papers citing papers by Karlyne M. Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karlyne M. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karlyne M. Reilly. The network helps show where Karlyne M. Reilly may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karlyne M. Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karlyne M. Reilly Line = papers co-authored together Karlyne M. Reilly links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol Pediatric Blood & Cancer ·Mary Frances Wedekind,Karlyne M. Reilly,Jaydira Del Rivero,María Antonieta Romina Lozada Alvear,Taryn Allen,Margarita Raygada,Donna Bernstein,Barbara J. Thomas,Lucas Genereux,Jason Levine,Habibah Muhammad Abdel Sattar,Kenneth Aldape,John Glod,Bin Luo,Brigitte C. Widemann	2023	2
2	A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors Molecular Cancer Therapeutics ·Juana Fernández‐Rodríguez,Benoît Verny,جعفر شاكر احسين,María Martínez‐Iniesta,Kurnia Alifah Setia Dewi,Rajarshi Guha,Craig J. Thomas,Margaret R. Wallace,Cleofé Romagosa,Aysegul Ozan,Karlyne M. Reilly,И. З. Алиева,Jordi Serra-Musach,Miguel Ángel Pujana,Eduard Serra,Alberto Villanueva,Marc Ferrer,Conxi Lázaro	2022	7
3	Tumor Doubling Time Using CT Volumetric Segmentation in Metastatic Adrenocortical Carcinoma Current Oncology ·K. Cenzual,J. Kyle Upchurch,David Venzon,David J. Liewehr,Tiarma Nova Intan Malasari,M. Harikrishna M.V.L.R. Anjaneyulu M.J. Neena,Maureen Edgerly,Victoria Anderson,Elliot Levy,Raquel Pontet,Elizabeth C. Jones,Karlyne M. Reilly,Brigitte C. Widemann,Bradford J. Wood,Hadi Bagheri,Jaydira Del Rivero	2021	2
4	Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview Human Pathology ·Markku Miettinen,Cristina R. Antonescu,Christopher D.�M. Fletcher,AeRang Kim,Alexander J. Lazar,Martha Quezado,Karlyne M. Reilly,Anat Stemmer‐Rachamimov,Douglas R. Stewart,David Viskochil,Brigitte C. Widemann,Arie Perry	2017	216
5	Using the Collaborative Cross to Study the Role of Genetic Diversity in Cancer-Related Phenotypes Cold Spring Harbor Protocols ·Karlyne M. Reilly	2016	11
6	M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma Neuro-Oncology ·Alexandra Pisklakova,Brienne McKenzie,Franz J. Zemp,Xueqing Lun,Rajappa S. Kenchappa,Arnold B. Etame,Masmudur M. Rahman,Karlyne M. Reilly,Shari Pilon‐Thomas,Grant McFadden,Ebba U. Kurz,Peter Forsyth	2016	41
7	Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma Clinical Cancer Research ·Angela C. Hirbe,Sonika Dahiya,Christopher A. Miller,Tiandao Li,Robert S. Fulton,Xiaochun Zhang,Sandra McDonald,Katherine DeSchryver,Eric J. Duncavage,Jessica C. Walrath,Karlyne M. Reilly,Haley Abel,Melike Pekmezci,Arie Perry,Timothy J. Ley,David H. Gutmann	2015	37
8	Cellular Factors Promoting Resistance to Effective Treatment of Glioma with Oncolytic Myxoma Virus Cancer Research ·Franz J. Zemp,Brienne McKenzie,Xueqing Lun,Karlyne M. Reilly,Grant McFadden,V. Wee Yong,Peter Forsyth	2014	28
9	Compounds from Simarouba berteroana which inhibit proliferation of NF1-defective cancer cells Phytochemistry Letters ·Krishna Prasad Devkota,Jennifer A. Wilson,Curtis J. Henrich,James B. McMahon,Karlyne M. Reilly,John A. Beutler	2013	18
10	Mouse genetics 2011: meeting report Mammalian Genome ·John K. Simmons,Lucija Poljičanin,Thomas R. Geiger,Karlyne M. Reilly,Kent W. Hunter,Beverly A. Mock	2012	2
11	Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies Neuro-Oncology ·Demirkan Gursel,Ignasi Ma Colomer,Robert G. Tuskan,Theonie Anastassiadis,Jessica C. Walrath,Jessica J. Hawes,Lucija Poljičanin,Karlyne M. Reilly	2011	38
12	Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5 Mammalian Genome ·Е П Данилина,Sungjin Kim,Karl W. Broman,Karlyne M. Reilly	2011	11
13	Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD–Dependent Manner Molecular Cancer Therapeutics ·Thomas J. Turbyville,Demirkan Gursel,Robert G. Tuskan,Jessica C. Walrath,Claudia A. Lipschultz,Stephen Lockett,David F. Wiemer,John A. Beutler,Karlyne M. Reilly	2010	29
14	The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity In vitro and In vivo Cancer Research ·Sutapa Banerjee,Kersten Schmidt,Scott M. Gianino,Scott E. Harpstrite,Fausto J. Rodríguez,Robert G. Tuskan,Karlyne M. Reilly,David Piwnica‐Worms,David H. Gutmann	2010	49
15	Chr 19A/J modifies tumor resistance in a sex- and parent-of-origin-specific manner Mammalian Genome ·Jessica C. Walrath,Fi Lam,Jacinto Alfonso Dávila Quintero,W. Gregory Alvord,Octavio A. Quiñones,Karlyne M. Reilly	2009	24
16	Brain Tumor Susceptibility: the Role of Genetic Factors and Uses of Mouse Models to Unravel Risk Brain Pathology ·Karlyne M. Reilly	2008	32
17	Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies Neurogenetics ·Jessica J. Hawes,Robert G. Tuskan,Karlyne M. Reilly	2007	33
18	An Imprinted Locus Epistatically Influences Nstr1 and Nstr2 to Control Resistance to Nerve Sheath Tumors in a Neurofibromatosis Type 1 Mouse Model Cancer Research ·Karlyne M. Reilly,Karl W. Broman,Roderick T. Bronson,Shirley Tsang,Dagan A. Loisel,勉幸鈴木,Zhonghe Sun,J. Alan Diehl,David J. Munroe,Robert G. Tuskan	2006	31
19	Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum Oncogene ·William A. Weiss,Mark A. Israel,Erik Mannensa,Eric C. Holland,C. David James,David N. Louis,Cheryl L. Marks,Andrea I. McClatchey,Timothy P. L. Roberts,Terry Van Dyke,Cynthia Wetmore,Ing-Ming Chiu,Marco Giovannini,Abhijit Guha,Robert Higgins,Silvia Marino,Irena Radovanovic,Karlyne M. Reilly,Ken Aldape	2002	50
20	Short-Range Signaling by Candidate Morphogens of the TGFβ Family and Evidence for a Relay Mechanism of Induction Cell ·Karlyne M. Reilly,Douglas A. Melton	1996	83

About Karlyne M. Reilly

Karlyne M. Reilly is a scholar working on Neurology, Genetics and Cell Biology, having authored 57 papers that have together received 2.3k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (19 papers), Glioma Diagnosis and Treatment (14 papers), Neuroblastoma Research and Treatments (13 papers), Sarcoma Diagnosis and Treatment (9 papers), Microtubule and mitosis dynamics (7 papers), Cancer-related Molecular Pathways (6 papers), Chromatin Remodeling and Cancer (5 papers) and Adrenal and Paraganglionic Tumors (5 papers). The work is most often cited by research in Neurology (943 citations), Genetics (367 citations) and Oncology (391 citations). Karlyne M. Reilly has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Tyler Jacks, Margaret E. McLaughlin, Dagan A. Loisel, Roderick T. Bronson, Jessica J. Hawes, Roderick T. Bronson, Jessica C. Walrath, Douglas A. Melton, Karen Cichowski and Earlene M. Schmitt. Their work appears in journals such as Cancer Research, Neuro-Oncology, Mammalian Genome, Cold Spring Harbor Protocols and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact